CRISPR Investments: Potential vs Realityby Mark Eisenberg 28.03.2024Despite plateauing venture funding in gene editing, the potential of CRISPR technology to revolutionize agriculture is still believed to be ...
Controversial Dengue Fever Solution: Biotech Company’s Offspring-Killing Methodby Lilu Anderson 28.03.2024Pesticides harm ecosystems by killing various insects, not just targeted ones. The mayor of Suzano hopes for a 20% reduction ...
Larry Fink Surprised by Bitcoin Rallyby John Darbie 28.03.2024Bitcoin's surge in value surprises many, with IBIT named the fastest-growing ETF ever. Foresight Ventures invests in The Block, as ...
Winnipeg Biotech Company’s Breakthrough in Phage Therapyby Lilu Anderson 28.03.2024Phage therapy, unlocking the potential of bacteria phages, is being used to treat antibiotic-resistant infections. It potentially saved a woman's ...
Boost Productivity with Top 43 Google Play Appsby Lilu Anderson 28.03.2024A recent study found 193 apps on Google Play Store with alarming access to personal data. 43 of these apps ...
Sichuan Kelun-Biotech Biopharmaceutical: Lowered Expectations Post Resultsby Mark Eisenberg 28.03.2024Losses are expected to increase by 32% to CN¥3.15 per share for Sichuan Kelun-Biotech Biopharmaceutical. This is a significant change ...
BlockDAG Surpasses DOGE Transactions with $600M Goalby John Darbie 28.03.2024Invest in BlockDAG for the best crypto security! With a Ledger hardware wallet, your digital assets are guaranteed protection. Get ...
Merck Stock Hits New High; Dow Outperformsby Mark Eisenberg 28.03.2024Stock and bond markets will be closed on Good Friday. Get expert advice straight to your e-mail for profitable opportunities. ...
NextCure, Inc.: Promising Growth Potential or Risky Investment?by Mark Eisenberg 28.03.2024NextCure, Inc. (NXTC) is a biopharmaceutical company focused on novel immunomedicines. Strong financials, positive outlook, and promising pipeline.
OptiNose, Inc.: Financial Report Reveals Stabilityby Mark Eisenberg 28.03.2024OptiNose Inc. (OPTN) is a pharmaceutical company specializing in ear, nose, and throat treatments. Recent revenue was $70.99 million. Stock ...